Contrast agent dose and slow/no-reflow in percutaneous coronary interventions : A case-control study of patients with non-ST-segment elevation acute coronary syndromes.
CONCLUSION: The contrast agent dose may be a risk factor for slow/no-reflow phenomenon after PTCA + stent in patients with NSTEACS. When the dose was greater than 160 ml, the risk of slow/no-reflow increased significantly.
PMID: 29637230 [PubMed - as supplied by publisher]
Source: Herz - Category: Cardiology Tags: Herz Source Type: research
More News: Angiography | Angioplasty | Baloon Angioplasty | Coronary Angioplasty | Diabetes | Diabetes Mellitus | Endocrinology | Percutaneous Coronary Intervention | Study | Thrombosis